Lixte Execs Trade, Founder Converts Options to RSUs—Insider Confidence Signals Bullish Outlook for Brain‑Cancer Biotech.
Insider moves at Lixte Biotechnology signal bullish confidence: CEO swaps options for immediate RSUs, hinting at potential stock rally tied to future clinical milestones.
- Lixte Biotechnology Holdings Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read